Literature DB >> 8800940

Age-adjusted recurrence risks for relatives of patients with multiple sclerosis.

N P Robertson1, M Fraser, J Deans, D Clayton, N Walker, D A Compston.   

Abstract

Familial aggregation is a cardinal epidemiological feature of multiple sclerosis, but few investigators have systematically examined recurrence risks for relatives of affected individuals in the United Kingdom. As part of a cross-sectional study of multiple sclerosis in Cambridgeshire, pedigree details were taken on 674 probands. Sex-specific, crude and age-adjusted recurrence risks were assessed amongst relatives of probands, applying a statistical model based on the observed age at onset of affected individuals and providing risks for clinical counselling. Details on year of birth, present age or age at death, and disease status were available on 11 391 relatives of successive probands. Nineteen percent of patients reported an additionally affected relative; 128 non-proband affected relatives were identified and the highest risk was observed for sisters. There was a systematic reduction in relative risk with genetic distance from the proband and no preferential recurrence for maternal or paternal relatives.

Entities:  

Mesh:

Year:  1996        PMID: 8800940     DOI: 10.1093/brain/119.2.449

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  44 in total

Review 1.  The genetic epidemiology of multiple sclerosis.

Authors:  A Compston
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

Review 2.  Genetic analysis of multiple sclerosis.

Authors:  Alastair Compston; Stephen Sawcer
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

3.  Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come.

Authors:  William S Bush; Stephen J Sawcer; Philip L de Jager; Jorge R Oksenberg; Jacob L McCauley; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Am J Hum Genet       Date:  2010-04-01       Impact factor: 11.025

Review 4.  Multiple sclerosis genetics--is the glass half full, or half empty?

Authors:  Jorge R Oksenberg; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

5.  A high-density screen for linkage in multiple sclerosis.

Authors:  Stephen Sawcer; Maria Ban; Mel Maranian; Tai Wai Yeo; Alastair Compston; Andrew Kirby; Mark J Daly; Philip L De Jager; Emily Walsh; Eric S Lander; John D Rioux; David A Hafler; Adrian Ivinson; Jacqueline Rimmler; Simon G Gregory; Silke Schmidt; Margaret A Pericak-Vance; Eva Akesson; Jan Hillert; Pameli Datta; Annette Oturai; Lars P Ryder; Hanne F Harbo; Anne Spurkland; Kjell-Morten Myhr; Mikko Laaksonen; David Booth; Robert Heard; Graeme Stewart; Robin Lincoln; Lisa F Barcellos; Stephen L Hauser; Jorge R Oksenberg; Shannon J Kenealy; Jonathan L Haines
Journal:  Am J Hum Genet       Date:  2005-07-29       Impact factor: 11.025

Review 6.  Genetic determinants of risk and progression in multiple sclerosis.

Authors:  Alessandro Didonna; Jorge R Oksenberg
Journal:  Clin Chim Acta       Date:  2015-02-04       Impact factor: 3.786

Review 7.  Genetic epidemiology of multiple sclerosis.

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

8.  The genetic aspects of multiple sclerosis.

Authors:  Stephen Sawcer
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

9.  Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.

Authors:  Jorge R Oksenberg; Lisa F Barcellos; Bruce A C Cree; Sergio E Baranzini; Teodorica L Bugawan; Omar Khan; Robin R Lincoln; Amy Swerdlin; Emmanuel Mignot; Ling Lin; Douglas Goodin; Henry A Erlich; Silke Schmidt; Glenys Thomson; David E Reich; Margaret A Pericak-Vance; Jonathan L Haines; Stephen L Hauser
Journal:  Am J Hum Genet       Date:  2003-12-10       Impact factor: 11.025

10.  The causal cascade to multiple sclerosis: a model for MS pathogenesis.

Authors:  Douglas S Goodin
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.